Close Menu

New synthetic biology tools may enable genetic engineers to play with metabolic pathways and the genetic code, according to the Economist.

For instance, it reports that Antheia, a firm founded by Christina Smolke, is working on designing new metabolic pathways to cheaply produce opiates for pain relief and to devise ones that are less addictive.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.